Loading organizations...
PHYX44 LABS has raised $1.2M across 1 funding round.
Key people at PHYX44 LABS.
PHYX44 LABS has raised $1.2M in total across 1 funding round.
Phyx44 Labs biodesigns novel functional proteins, specializing in cell-derived replacements for traditional dairy. The company utilizes precision fermentation to create nature-identical protein alternatives, including Swey, Proferrin, Numino, and Aphróse. This approach yields sustainable ingredients for diverse food and nutrition applications, moving beyond conventional animal-derived sources.
Founded in 2021 by Bharath Bakaraju, Phyx44 Labs operates from Bangalore, India. Bakaraju established the company, driven by the insight that advanced biotechnological methods could provide sustainable, ethical protein sources. This foundation addresses global demand for alternative food systems by leveraging microbial hosts to precisely produce specific proteins.
Phyx44 Labs provides innovative protein components to the food and nutrition industry. Its vision centers on transforming the global food supply chain through bio-designed ingredients that are both highly functional and environmentally conscious. The company aims to be a pivotal enabler in the transition towards a more sustainable and resilient future of food.
Key people at PHYX44 LABS.
PHYX44 LABS has raised $1.2M across 1 funding round. Most recently, it raised $1.2M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 9, 2022 | $1.2M Seed | — | Rohit Gulati, Sandhya Sriram, Jinesh Shah, Better Bite Ventures, BIG Idea Ventures, Humane Society International, PeerCapital, Spectrum Impact | Announced |
Phyx44 Labs (also referred to as Phyx44) is a cellular agriculture startup founded in 2021, specializing in precision fermentation to produce animal-free dairy proteins and fats that are molecularly identical to traditional dairy. It recreates milk and derivatives like whey, casein, and fatty acids using microbes, targeting food manufacturers and consumers seeking lactose-free, low-carbon alternatives with the same taste and functionality.[1][2][3][5] Based primarily in Bangalore, India, with a registered address in Singapore, the company has raised $1.33M in seed funding, including a $1.2M round in 2023 led by Better Bite Ventures, to scale R&D and partner co-development.[1][2] It serves the global alternative dairy market, solving sustainability issues in dairy production—such as high emissions, land use, and animal welfare—while leveraging India's low-cost biotech infrastructure for affordable scaling.[2][3]
Phyx44 was founded in early 2021 in Bangalore, India, as the country's first full-stack precision fermentation startup for dairy alternatives.[2] Specific founders are not named in available sources, but the team quickly demonstrated technical prowess by scaling to a 100L fermentation capacity shortly after launch, earning investment from prominent backers like Better Bite Ventures (led by Michal Klar), Ahimsa VC (Jinesh Shah), Rohit Gulati (Boston Consulting Group), Sandhya Sriram (Shiok Meats CEO), and others.[2] The idea emerged at the intersection of India's status as the world's largest dairy producer/consumer and its pharma/biotech strengths, positioning the company to replicate cow genes in microbes for efficient, planet-friendly dairy proteins.[2][3] Early traction came via seed funding to accelerate R&D, team expansion, and product formulation partnerships, with aspirations to make India a "smart protein factory" for global markets.[1][2]
Phyx44 stands out in the alt-dairy space through these key strengths:
Competitors like Time-travelling Milkman (plant-based fats) and Genuine Taste (stem-cell fats for meat) focus on narrower niches, while Phyx44's microbe-based, dairy-complete approach offers broader versatility.[1]
Phyx44 rides the surging wave of cellular agriculture and precision fermentation, a trend exploding amid climate pressures on animal agriculture—dairy alone contributes massively to global emissions.[2][3] Timing is ideal: India's dual role as dairy giant and biotech hub (e.g., pharma exports) provides unique leverage for sustainable scaling, especially as consumer demand for animal-free, lactose-free options grows in Asia and beyond.[1][2] Market tailwinds include falling fermentation costs, regulatory nods for alt-proteins, and investor enthusiasm for foodtech climate solutions, positioning Phyx44 to supply ingredients to global food makers.[1][2] It influences the ecosystem by proving India can lead "Dairy 2.0," inspiring similar ventures and accelerating the shift to microbe-brewed foods that preserve dairy's appeal without environmental harm.[3]
Phyx44 is primed to disrupt dairy supply chains with its India-centric, full-stack model, potentially capturing share in a market hungry for scalable, identical-tasting alternatives. Next steps likely include commercial pilots, expanded partnerships, and larger funding as it hits pilot-scale production—watch for 2026 product launches amid tightening global sustainability mandates.[1][2] Trends like AI-optimized fermentation, Asia's rising alt-protein adoption, and policy incentives for low-emission foods will propel it, evolving its role from startup to key global supplier. This "new brew" could redefine dairy, delivering the creaminess we crave while sparing cows and the planet—echoing its mission from day one.[3]
PHYX44 LABS has raised $1.2M in total across 1 funding round.
PHYX44 LABS's investors include Rohit Gulati, Sandhya Sriram, Jinesh Shah, Better Bite Ventures, Big Idea Ventures, Humane Society International, PeerCapital, Spectrum Impact.
